The aim of our study was to evaluate the optimal implantation height of the SAPIEN 3. Methods and ResultsWe analysed the correlation between the implantation height of the valve and the need for PPM in 131 pati
由于外科手术的主动脉瓣或二尖瓣瓣膜失效,SAPIEN3瓣膜是唯一经批准可用于瓣中瓣手术的瓣膜。 SAPIEN3瓣中瓣尺寸指南 主动脉瓣 二尖瓣 革新性的瓣膜设计 概述更小的入路血管尺寸要求显示重大血管并发症显著减少‡裙缘聚对苯二甲酸乙二醇酯(PET)外部裙缘旨在最大限度地减少瓣周漏*瓣膜组织使用与Edwards外科手术瓣膜相...
与以往的自膨胀式瓣膜相比,SAPIEN 3瓣膜的输送系统外径小、可调弯,定位精准,瓣膜长度较短,瓣膜径向支撑力更大,这为手术风险高、冠脉闭塞高风险、起搏器植入高风险的患者提供更优的选择。 SAPIEN 3是最新一代的球囊扩张式经导管主动脉瓣系...
作为首款进入我国的进口经导管主动脉瓣膜系统, Edwards Sapien 3球扩瓣膜使用14F可扩张式导管鞘,当瓣膜系统通过时,可短暂性的部分扩张,减少血管损伤;Sapien 3球扩瓣膜使用Commander输送系统,这是目前唯一一个可调弯的输送系统,可进行双弯...
The Heart (3) Aortic Stenosis (4) Aortic Valve Replacement Options (5) Deciding on the Right Treatment Option for You (6) The Edwards SAPIEN 3 TAVR ...7-8 The Edwards SAPIEN 3 TAVR Procedure...9-10 After Your Edwards SAPIEN 3 TAVR Procedure......
最近一项研究显示,SAPIEN 3的置入深度和超大尺寸是植入新型永久性起搏器的独立预测因子,提示选择不太大的瓣膜及偏高位置可能会降低起搏器植入率。采用这种策略,一项对欧洲101例中度危险分层患者的分析表明,SAPIEN 3置入后需植入心脏起搏器的发生率很低。 本例患者SAPIEN 3置入术为国内首例,未出现并发症,只有轻微瓣周...
The aim of this study was to evaluate the influence of implantation depth on PVL and PMI after ESV-3 implantation Methods We enrolled 231 consecutive pts who underwent successfully transfemoral TAVI in local anesthesia using the ESV-3 valve (23,26,29mm). CT-imaging including the Heart Navigator...
New persistent left bundle branch block (NP-LBBB) has been associated with adverse outcomes after transcatheter aortic valve replacement (TAVR), but few predictors have thus far been reported. We sought to identify predictors of NP-LBBB after TAVR with the Edwards Sapien3 (S3) valve. Methods Fr...
and functionality of the devices after reprocessing. Incorrect sizing of the valve may lead to paravalvular leak, migration, embolization, residual gradient (patient-prosthesis mismatch), and/or annular rupture. Accelerated deterioration of the valve due to calcific degeneration may occur in children, ...
Edwards SAPIEN 3 Transcatheter Heart Valve and Accessories产品名称,P140031 S084申请号,PMA申请类型,EDWARDS LIFESCIENCES, LLC.申请人,数据来源于药智数据美国上市器械数据库。